SmithRx has successfully closed a $60 million Series C funding round.
We believe this additional capital will help us greatly accelerate the realisation of our ambitious goals.
We founded SmithRx with the idea that the pharmacy benefits management system could be dramatically improved to benefit everyone.
[
add
]
[
|
|
...
]